KVACU

FINANCIAL SERVICES

Keen Vision Acquisition Corporation Units

—+0.00 (+0.00%)LIVE

Live · NASDAQ · May 13, Close

AI Insight

What's Moving KVACU Today?

No stock-specific AI insight has been generated for KVACU yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap—

P/E Ratio—

EPS—

Dividend Yield—

Dividend / Share—

ROE—

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding—

KVACU News

4 articles

Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated CardiomyopathyYahoo Finance·Jul 15, 2025
Medera’s Novoheart Enters New Collaboration to Develop Human Mini-Heart Models Aimed at Transforming Treatment for Hypoplastic Left Heart SyndromeYahoo Finance·Jun 24, 2025
Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025Yahoo Finance·Jun 13, 2025
Medera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 CongressYahoo Finance·May 19, 2025

All 4 articles loaded

Price Data

Open—

Previous Close—

Day High—

Day Low—

52 Week High$11.50

52 Week Low$10.40

Fundamentals

Market Cap—

P/E Ratio—

EPS—

Dividend Yield—

Dividend / Share—

ROE—

Profit Margin—

Debt / Equity—

Trading

Volume—

Avg Volume (10D)—

Shares Outstanding—

About Keen Vision Acquisition Corporation Units

Keen Vision Acquisition Corporation intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, and related business combination with one or more businesses or entities.

kv-ac.com

Listed July 25, 2023

FINANCIAL SERVICESSHELL COMPANIES

Company Details

Security TypeCommon Stock

ExchangeNASDAQ

CurrencyUSD

Round Lot—

SICSHELL COMPANIES

CIK—

Composite FIGI—

Share Class FIGI—